The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Vaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development
Open accessAbstract
Vaxign is the first web-based vaccine design system that predicts vaccine targets based on genome sequences using the strategy of reverse vaccinology. Predicted features in the Vaxign pipeline include protein subcellular location, transmembrane helices, adhesin probability, conservation to human and/or mouse proteins, sequence exclusion from genome(s) of nonpathogenic strain(s), and epitope binding to MHC class I and class II. The precomputed Vaxign database contains prediction of vaccine targets for>70genomes. Vaxign also performs dynamic vaccine target prediction based on input sequences. To demonstrate the utility of this program, the vaccine candidates against uropathogenic Escherichia coli(UPEC) were predicted using Vaxign and compared with various experimental studies. Our results indicate that Vaxign is an accurate and efficient vaccine design program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Measuring the Accuracy of Diagnostic Systems
Swets, J. A. (1988) · Science · doi:10.1126/science.3287615 · Cited by 10,058
The Complete Genome Sequence of Escherichia coli K-12
Blattner, F. R., Plunkett, G., Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C. K., Mayhew, G. F., et al. (1997) · Science · doi:10.1126/science.277.5331.1453 · Cited by 7,452
OrthoMCL: Identification of Ortholog Groups for Eukaryotic Genomes
Li, L., Stoeckert, C. J., & Roos, D. S. (2003) · Genome Research · doi:10.1101/gr.1224503 · Cited by 5,707 · cited 3×
“Compared to a conventional vaccine development approach that starts from the wet laboratory, reverse vaccinology begins with bioinformatics analysis, which dramatically quickens the process of vaccine development.”
BackgroundResultPruitt, K. D., Tatusova, T., & Maglott, D. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,481
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Advantages of combined transmembrane topology and signal peptide prediction--the Phobius web server
Kall, L., Krogh, A., & Sonnhammer, E. L. L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm256 · Cited by 1,677
Pruitt, K. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki025 · Cited by 1,660
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Combining evidence using p-values: application to sequence homology searches.
Bailey, T. L., & Gribskov, M. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.1.48 · Cited by 1,253
Modulation of natural killer cell activity by viruses
Lisnić, V. J., Krmpotić, A., & Jonjić, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.011 · Cited by 1,003
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9827 · Cited by 735
Gardy, J. L., Laird, M. R., Chen, F., Rey, S., Walsh, C. J., Ester, M., & Brinkman, F. S. L. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti057 · Cited by 718
Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 704
X-ray Structure of the FimC-FimH Chaperone-Adhesin Complex from Uropathogenic Escherichia coli
Choudhury, D., Thompson, A., Stojanoff, V., Langermann, S., Pinkner, J., Hultgren, S. J., & Knight, S. D. (1999) · Science · doi:10.1126/science.285.5430.1061 · Cited by 610
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., et al. (1997) · Science · doi:10.1126/science.276.5312.607 · Cited by 577
T-cell antigenic sites tend to be amphipathic structures.
DeLisi, C., & Berzofsky, J. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7048 · Cited by 515
Exact prediction of a natural T cell epitope
Rötzschke, O., Falk, K., Stevanovic, S., Jung, G., Walden, P., & Rammensee, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211136 · Cited by 446
Reche, P., Glutting, J.-P., Zhang, H., & Reinherz, E. (2004) · Immunogenetics · doi:10.1007/s00251-004-0709-7 · Cited by 386
Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection
Snyder, J. A., Haugen, B. J., Buckles, E. L., Lockatell, C. V., Johnson, D. E., Donnenberg, M. S., Welch, R. A., & Mobley, H. L. T. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6373-6381.2004 · Cited by 381
Self-citationThe Immune Epitope Database and Analysis Resource: From Vision to Blueprint
Peters, B., Sidney, J., Bourne, P., Bui, H.-H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030091 · Cited by 373
Wizemann, T. M., Heinrichs, J. H., Adamou, J. E., Erwin, A. L., Kunsch, C., Choi, G. H., Barash, S. C., Rosen, C. A., Masure, H. R., Tuomanen, E., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1593-1598.2001 · Cited by 351
Langermann, S., Möllby, R., Burlein, J. E., Palaszynski, S. R., Auguste, C. G., DeFusco, A., Strouse, R., Schenerman, M. A., Hultgren, S. J., Pinkner, J. S., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315258 · Cited by 336
Sette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., & Grey, H. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3296 · Cited by 310
Blocks+: a non-redundant database of protein alignment blocks derived from multiple compilations.
Henikoff, S., Henikoff, J. G., & Pietrokovski, S. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.6.471 · Cited by 291
A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules
Peters, B., Bui, H.-H., Frankild, S., Nielsen, M., Lundegaard, C., Kostem, E., Basch, D., Lamberth, K., Harndahl, M., Fleri, W., et al. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020065 · Cited by 288
Torres, A. G., Redford, P., Welch, R. A., & Payne, S. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6179-6185.2001 · Cited by 287
UROLOGIC DISEASES IN AMERICA PROJECT: ANALYTICAL METHODS AND PRINCIPAL FINDINGS
LITWIN, M. S., SAIGAL, C. S., YANO, E. M., AVILA, C., GESCHWIND, S. A., HANLEY, J. M., JOYCE, G. F., MADISON, R., PACE, J., POLICH, S. M., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000152365.43125.3b · Cited by 254
Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection
Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N., & Mobley, H. L. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000586 · Cited by 201
Self-citationGenomic Approach for Analysis of Surface Proteins in Chlamydia pneumoniae
Montigiani, S., Falugi, F., Scarselli, M., Finco, O., Petracca, R., Galli, G., Mariani, M., Manetti, R., Agnusdei, M., Cevenini, R., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.368-379.2002 · Cited by 200
Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains
Naves, P., del Prado, G., Huelves, L., Gracia, M., Ruiz, V., Blanco, J., Dahbi, G., Blanco, M., del Carmen Ponte, M., & Soriano, F. (2008) · Microbial Pathogenesis · doi:10.1016/j.micpath.2008.03.003 · Cited by 188
SPAAN: a software program for prediction of adhesins and adhesin-like proteins using neural networks
Sachdeva, G., Kumar, K., Jain, P., & Ramachandran, S. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti028 · Cited by 188
Immuno‐informatics: Mining genomes for vaccine components
De Groot, A. S., Sbai, H., Aubin, C. S., McMurry, J., & Martin, W. (2002) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2002.01092.x · Cited by 179
Predicting transmembrane beta-barrels in proteomes
Bigelow, H., Petrey, D. S., Liu, J., Przybylski, D., & Rost, B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh580 · Cited by 161
Uropathogenic Escherichia coli Outer Membrane Antigens Expressed during Urinary Tract Infection
Hagan, E. C., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00337-07 · Cited by 159
Self-citationImmunomics: discovering new targets for vaccines and therapeutics
Groot, A. S. D. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03720-7 · Cited by 154
Sette, A., Sidney, J., Oseroff, C., del Guercio, M. F., Southwood, S., Arrhenius, T. S., Powell, M. F., Colon, S. M., Gaeta, F. C., & Grey, H. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.6.3163 · Cited by 148
Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis
Ross, B. C., Czajkowski, L., Hocking, D. M., Margetts, M. B., Webb, E., Rothel, L., Patterson, M., Agius, C. T., Camuglia, S., Reynolds, E. C., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00173-6 · Cited by 141
Alteri, C. J., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00076-07 · Cited by 141
Self-citationAriel, N., Zvi, A., Grosfeld, H., Gat, O., Inbar, Y., Velan, B., Cohen, S. B., & Shafferman, A. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6817-6827.2002 · Cited by 136
NERVE: New Enhanced Reverse Vaccinology Environment
Vivona, S., Bernante, F., & Filippini, F. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-35 · Cited by 130
Phase 2 Clinical Trial of a Vaginal Mucosal Vaccine for Urinary Tract Infections
Uehling, D. T., Hopkins, W. J., Elkahwaji, J. E., SCHMIDT, D., & LEVERSON, G. E. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000075094.54767.6e · Cited by 117
T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆
Weber, C. A., Mehta, P. J., Ardito, M. T., Moise, L., Martin, B., & Groot, A. S. D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.001 · Cited by 114
Chakravarti, D. N., Fiske, M. J., Fletcher, L. D., & Zagursky, R. J. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00256-5 · Cited by 108
Alteri, C. J., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00076-06 · Cited by 102
Self-citationGroot, A. S. D., Jesdale, B. M., Szu, E., Schafer, J., Chicz, R. M., & DEOCAMPO, G. (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.529 · Cited by 100
Russo, T. A., McFadden, C. D., MacDonald, U., Beanan, J. M., Olson, R., & Wilding, G. E. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7164-7169.2003 · Cited by 95
HIV vaccine development by computer assisted design: the GAIA vaccine
Groot, A. S. D., Marcon, L., Bishop, E. A., Rivera, D. S., Kutzler, M. A., Weiner, D. B., & Martin, W. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.097 · Cited by 88
Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics
Walters, M. S., & Mobley, H. L. T. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.04.013 · Cited by 74
Self-citationVaxign: a web-based vaccine target design program for reverse vaccinology
Xiang, Z., & He, Y. O. (2009) · Procedia in Vaccinology · doi:10.1016/j.provac.2009.07.005 · Cited by 70
Self-citationAn empirical method for the prediction of T-cell epitopes
Davenport, M. P., Shon, I. A. H., & Hill, A. (1995) · Immunogenetics · doi:10.1007/bf00179401 · Cited by 70
MHCPEP: a database of MHC-binding peptides
Brusić, V., Rudy, G. B., & Harrison, L. C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.17.3663 · Cited by 69
Durant, L., Métais, A., Soulama-Mouze, C., Genevard, J.-M., Nassif, X., & Escaich, S. (2006) · Infection and Immunity · doi:10.1128/iai.01269-06 · Cited by 66
Betts, J. C. (2002) · IUBMB Life · doi:10.1080/15216540212651 · Cited by 63
Wilson, C., Tiwana, H., & Ebringer, A. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01303-4 · Cited by 58
Kumar, V., Ganguly, N. K., Joshi, K., Mittal, R., Harjai, K., Chhibber, S., & Sharma, S. (2005) · Medical Microbiology and Immunology · doi:10.1007/s00430-005-0241-x · Cited by 10
Cited by
Fundamentals and Methods for T- and B-Cell Epitope Prediction
Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/2680160 · Cited by 674
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01581 · Cited by 499
“Among current RV prediction tools (14, 15), Vaxign is the first web-based RV program (16) and has been used to predict vaccine candidates against different bacterial and viral pathogens (17–19).”
InfluentialSelf-citationSynthetic Biology and Personalized Medicine
Jain, K. K. (2013) · Medical Principles and Practice · doi:10.1159/000341794 · Cited by 376
Urinary Tract Infections: Current and Emerging Management Strategies
Barber, A. E., Norton, J. P., Spivak, A. M., & Mulvey, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit284 · Cited by 262
Kazi, A., Chuah, C., Majeed, A. B. A., Leow, C. H., Lim, B. H., & Leow, C. Y. (2018) · Pathogens and Global Health · doi:10.1080/20477724.2018.1446773 · Cited by 122
Metadata
- Authors
- He, Y., Xiang, Z., & Mobley, H. L. T.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Wiley
- Published
- 2010
- Volume
- 2010
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W2005095482
- Cited by
- 355
- References
- 58
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.